24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2022
BiblioTech
Boarding Pass
Startup: Confidential
Appointments
CTalk
Tech Gateways
2022 VC Survey
@Finance
Ctech Testimonials
Shopping
Projects
About
Newsletter
Contact us
RSS
Facebook
Twitter
ACCESSIBILITY
by
Homepage
CartiHeal
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
Terms Of Use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
11:20
Uncertainty looms over future of Zisapel tech empire
11:00
Xiaomi's Wear OS move: What you need to know about the Watch 2
10:40
From Arrow 4 to laser interceptors: Israel's air defense is about to level up
10:15
Empowering Makers: Inside the TOM workshops reshaping lives
More stories
Buzz
Most popular
Daily
Weekly
1
Israeli Billionaire Hires Black Cube to Spy on Former Partner Company Vale
2
Nvidia announces $700 million acquisition of Run:ai
3
Sheryl Sandberg's harrowing documentary exposes Hamas sex crimes
4
Nvidia continues Israel shopping spree with acquisition of Deci
5
From Arrow 4 to laser interceptors: Israel's air defense is about to level up
More news
CartiHeal
3 stories about CartiHeal
Biomed company CartiHeal acquired by Smith & Nephew for up to $330 million
22.11.23
|
Meir Orbach
The Israeli firm, which develops a biocompatible, coral-based, off-the-shelf implant for damaged joints, will initially receive $180 million in cash and up to a further $150 million contingent on financial performance
Israeli medtech company CartiHeal to be acquired for $500 million by Bioventus
30.08.21
|
Golan Hazani
The American orthobiologics company announced that it has activated its option to purchase the Kfar Saba-based company by transferring an initial $50 million
Biomed Company CartiHeal Considers a Nasdaq IPO
26.02.20
|
Golan Hazani
The company is looking to raise between $60 million and $80 million according to a valuation of $300 million to $400 million and has already hired Credit Suisse and Jefferies for this purpose, according to two people familiar with the matter
Please ensure Javascript is enabled for purposes of
website accessibility